Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ivan Monteleone

Showing results (41-50 of 85) with videos related to

Pageof 9
Sort By:
Gastroenterology|July 24, 2012
Tissue inhibitor of metalloproteinase-3 regulates inflammation in human and mouse intestineIvan Monteleone, Massimo Federici, Massimiliano Sarra, et al.
Journal of Crohn'S & Colitis|July 2, 2024
Bromodomain-containing 4 is a positive regulator of the inflammatory cytokine response in the gutEleonora Franzè, Federica Laudisi, Claudia Maresca, et al.
Journal of Crohn'S & Colitis|February 5, 2019
Neutrophil Extracellular Traps Sustain Inflammatory Signals in Ulcerative ColitisVincenzo Dinallo, Irene Marafini, Davide Di Fusco, et al.
Inflammatory Bowel Diseases|April 19, 2018
Knockdown of Smad7 With a Specific Antisense Oligonucleotide Attenuates Colitis and Colitis-Driven Colonic Fibrosis in MiceRoberta Izzo, Gerolamo Bevivino, Veronica De Simone, et al.
Clinical Science (London, England : 1979)|March 16, 2018
Metformin inhibits inflammatory signals in the gut by controlling AMPK and p38 MAP kinase activationDavide Di Fusco, Vincenzo Dinallo, Ivan Monteleone, et al.
Inflammatory Bowel Diseases|June 1, 2004
CARD15 mutation analysis in an Italian population: Leu1007fsinsC but neither Arg702Trp nor Gly908Arg mutations are associated with Crohn's diseasePiero Vavassori, Paola Borgiani, Livia Biancone, et al.
Clinical Science (London, England : 1979)|March 23, 2012
2-Methoxy-5-amino-N-hydroxybenzamide, a derivative of mesalamine, inhibits colon cancer cell growth through cyclo-oxygenase-2-dependent and -independent mechanismsCarmine Stolfi, Eleonora Franzè, Ivan Monteleone, et al.
Cancer Science|September 6, 2024
Rafoxanide negatively modulates STAT3 and NF-κB activity and inflammation-associated colon tumorigenesisTeresa Pacifico, Carmine Stolfi, Lorenzo Tomassini, et al.
Frontiers in Immunology|March 18, 2025
High Smad7 marks inflammation in patients with chronic pouchitisClaudia Maresca, Andrea Iannucci, Marco Colella, et al.
Experimental Hematology & Oncology|September 28, 2024
Targeting hepcidin in colorectal cancer triggers a TNF-dependent-gasdermin E-driven immunogenic cell death responseAntonio Di Grazia, Eleonora Franzè, Rachele Frascatani, et al.
Pageof 9

Showing results (41-50 of 85) with videos related to

Sort By:
Pageof 9
Gastroenterology|July 24, 2012
Tissue inhibitor of metalloproteinase-3 regulates inflammation in human and mouse intestineIvan Monteleone, Massimo Federici, Massimiliano Sarra, et al.
Journal of Crohn'S & Colitis|July 2, 2024
Bromodomain-containing 4 is a positive regulator of the inflammatory cytokine response in the gutEleonora Franzè, Federica Laudisi, Claudia Maresca, et al.
Journal of Crohn'S & Colitis|February 5, 2019
Neutrophil Extracellular Traps Sustain Inflammatory Signals in Ulcerative ColitisVincenzo Dinallo, Irene Marafini, Davide Di Fusco, et al.
Inflammatory Bowel Diseases|April 19, 2018
Knockdown of Smad7 With a Specific Antisense Oligonucleotide Attenuates Colitis and Colitis-Driven Colonic Fibrosis in MiceRoberta Izzo, Gerolamo Bevivino, Veronica De Simone, et al.
Clinical Science (London, England : 1979)|March 16, 2018
Metformin inhibits inflammatory signals in the gut by controlling AMPK and p38 MAP kinase activationDavide Di Fusco, Vincenzo Dinallo, Ivan Monteleone, et al.
Inflammatory Bowel Diseases|June 1, 2004
CARD15 mutation analysis in an Italian population: Leu1007fsinsC but neither Arg702Trp nor Gly908Arg mutations are associated with Crohn's diseasePiero Vavassori, Paola Borgiani, Livia Biancone, et al.
Clinical Science (London, England : 1979)|March 23, 2012
2-Methoxy-5-amino-N-hydroxybenzamide, a derivative of mesalamine, inhibits colon cancer cell growth through cyclo-oxygenase-2-dependent and -independent mechanismsCarmine Stolfi, Eleonora Franzè, Ivan Monteleone, et al.
Cancer Science|September 6, 2024
Rafoxanide negatively modulates STAT3 and NF-κB activity and inflammation-associated colon tumorigenesisTeresa Pacifico, Carmine Stolfi, Lorenzo Tomassini, et al.
Frontiers in Immunology|March 18, 2025
High Smad7 marks inflammation in patients with chronic pouchitisClaudia Maresca, Andrea Iannucci, Marco Colella, et al.
Experimental Hematology & Oncology|September 28, 2024
Targeting hepcidin in colorectal cancer triggers a TNF-dependent-gasdermin E-driven immunogenic cell death responseAntonio Di Grazia, Eleonora Franzè, Rachele Frascatani, et al.
Pageof 9